Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Proceedings of the American Pharmaceutical Manufacturers' Association, Annual Meeting
  • Language: en
  • Pages: 272
The Influence of the Pharmaceutical Industry
  • Language: en
  • Pages: 556

The Influence of the Pharmaceutical Industry

Incorporating HC 1030-i to iii.

American Pharmacy (1852-2002)
  • Language: en
  • Pages: 148

American Pharmacy (1852-2002)

Essays reprinted from the Journal of the American Pharmaceutical Association series commemorating the sesquicentennial of the American Pharmaceutical Association.

Medical Monopoly
  • Language: en
  • Pages: 345

Medical Monopoly

"Drawing on a wealth of previously overlooked archival material, 'Medical Monopoly' combines legal, medical, and business history to offer a sweeping new interpretation of the origins of the complex and often troubling relationship between the pharmaceutical industry and medical practice today. Joseph M. Gabriel provides the first detailed history of patent and trademark law as it relates to the nineteenth century pharmaceutical industry, as well as unique interpretation of medical ethics, therapeutic reform, and efforts to regulate the market in pharmaceuticals before World War I"--Dust jacket.

Bad Pharma
  • Language: en
  • Pages: 479

Bad Pharma

  • Type: Book
  • -
  • Published: 2014-04
  • -
  • Publisher: Macmillan

Originally published in 2012, revised edition published in 2013, by Fourth Estate, Great Britain; Published in the United States in 2012, revised edition also, by Faber and Faber, Inc.

Medical Technology Assessment Directory
  • Language: en
  • Pages: 709

Medical Technology Assessment Directory

For the first time, a single reference identifies medical technology assessment programs. A valuable guide to the field, this directory contains more than 60 profiles of programs that conduct and report on medical technology assessments. Each profile includes a listing of report citations for that program, and all the reports are indexed under major subject headings. Also included is a cross-listing of technology assessment report citations arranged by type of technology headings, brief descriptions of approximately 70 information sources of potential interest to technology assessors, and addresses and descriptions of 70 organizations with memberships, activities, publications, and other functions relevant to the medical technology assessment community.

The Truth About the Drug Companies
  • Language: en
  • Pages: 334

The Truth About the Drug Companies

  • Type: Book
  • -
  • Published: 2004-08-24
  • -
  • Publisher: Random House

During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes the shocking truth of ...

The Global Politics of Pharmaceutical Monopoly Power
  • Language: en
  • Pages: 136

The Global Politics of Pharmaceutical Monopoly Power

  • Type: Book
  • -
  • Published: 2009
  • -
  • Publisher: Unknown

In The Global Politics of Pharmaceutical Monopoly Power, researcher and global advocate Ellen 't Hoen explains how new global rules for pharmaceutical patenting impact access to medicines in the developing world. The book gives an account of the current debates on intellectual property, access to medicines, and medical innovation, and provides historical context that explains how the current system emerged. This book supports major policy changes in the management of pharmaceutical patents and the way medical innovation is financed in order to protect public health and, in particular, promote access to essential medicines for all. The Open Society Institute provided support to translate this report into Russian.